331 related articles for article (PubMed ID: 15810951)
1. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
Parsons A; Sheehan DJ; Sangueza OP
Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
[TBL] [Abstract][Full Text] [Related]
5. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
Galambos C; Nodit L
Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
8. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
9. Unclassified epithelioid vascular tumor with hemangioendotheliomatous features and lymphatic differentiation.
Oshiro Y; Kohashi K; Oda Y; Tsuneyoshi M; Shono Y
Pathol Int; 2009 Jun; 59(6):410-4. PubMed ID: 19490473
[TBL] [Abstract][Full Text] [Related]
10. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
11. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
Mankey CC; McHugh JB; Thomas DG; Lucas DR
Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
[TBL] [Abstract][Full Text] [Related]
12. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
[TBL] [Abstract][Full Text] [Related]
14. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
15. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40.
Dubina M; Goldenberg G
J Am Acad Dermatol; 2009 Aug; 61(2):276-80. PubMed ID: 19615538
[TBL] [Abstract][Full Text] [Related]
16. WT1 expression in angiogenic tumours of the skin.
Timár J; Mészáros L; Orosz Z; Albini A; Rásó E
Histopathology; 2005 Jul; 47(1):67-73. PubMed ID: 15982325
[TBL] [Abstract][Full Text] [Related]
17. TAL-1 protein expression in vascular lesions.
Chetty R; Dada MA; Boshoff CH; Comley MA; Biddolph SC; Schneider JW; Mason DY; Pulford KA; Gatter KC
J Pathol; 1997 Mar; 181(3):311-5. PubMed ID: 9155718
[TBL] [Abstract][Full Text] [Related]
18. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
Gomaa AH; Yaar M; Bhawan J
Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
[TBL] [Abstract][Full Text] [Related]
20. Histomorphometrical study in cavernous lymphangioma of the tongue.
Yaita T; Onodera K; Xu H; Ooya K
Oral Dis; 2007 Jan; 13(1):99-104. PubMed ID: 17241438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
